EyePoint (EYPT) Amortization - Intangibles (2019 - 2022)

EyePoint (EYPT) posted Amortization - Intangibles of $205000.0 for Q4 2022, down 66.67% sequentially from $615000.0 in Q3 2022.

EyePoint (EYPT) Amortization - Intangibles (2019 - 2022) Analysis & Trends

EyePoint has reported Amortization - Intangibles for 2 years, with the latest figure at $205000.0 in Q4 2022.

Quarterly Amortization - Intangibles changed N/A year-over-year to $205000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2023 was $820000.0 (down 42.86% YoY) and the FY2022 annual result came in at $2.0 million, changed N/A from the prior year.
Amortization - Intangibles retreated to $205000.0 in Q4 2022 per EYPT's latest filing, from $615000.0 in the prior quarter.
Over five years, Amortization - Intangibles peaked at $615000.0 in Q1 2019 and troughed at $205000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	EyePoint	1.25 Bn	1.07 Bn	507,000.00

Download Data